Topic: contract manufacturer
Foshan Jinxiong Technology has been on an import alert list since February, banning all of its products from entering the U.S.
The North American expansions come amid a restructuring at Evonik, which aims to save €200 million in cost by the end of 2020.
A Durham, North Carolina-based CDMO with 10 locations globally is being picked up in a deal by private equity.
Contract manufacturer Avara is taking advantage of Sandoz's slimdown efforts by buying a sterile manufacturing plant in Quebec.
Betting heavily on a less-regulated CMO market, a Chinese company intends to build a massive biologics plant over the next several years.
China CDMO WuXi Biologics has picked Ireland for its first biologics plant outside of China, a facility in which it will invest €325 million.
Thermo Fisher features its employees and the patients they help in a new campaign that personalizes its drug development and delivery services.
Washington-based CDMO AGC Biologics said it will expand its headquarters and manufacturing capacity.
Two European manufacturing plants discarded by Big Pharma have been bought by Asian companies and reopened.